bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.06.05.730443

Local SNP-explained methylation variation reveals genetically anchored and exposure-associated methylation architecture in the human brain

Abstract

Human brain DNA methylation is shaped by inherited genetic variation and cumulative environmental experience, yet how these influences partition the methylome remains poorly resolved in postmortem cohorts with modest sample sizes and limited ancestral diversity. To map this architecture in an underrepresented population, we analyzed whole-genome bisulfite sequencing and genotype array data from 168 admixed Black American adults from the BrainSEQ consortium across three brain regions. We adapted and benchmarked SNP-based elastic-net modeling to classify variably methylated regions (VMRs) by local SNP-explained methylation variation, an approach that provided stable classification at the modest sample sizes of postmortem brain cohorts, where conventional methods are underpowered. Using this framework, we partitioned 31,143 VMRs into high and low SNP-explained classes and evaluated their generalizability in a multi-ancestry cohort of Black American and non-Hispanic white American donors. High SNP-explained VMRs were concentrated in distal intergenic sequences and, at the highest heritability levels, were enriched for H3K9me3, quiescent/repressive chromatin states and LINE/L1 elements, linking genetically anchored methylation to repeat-associated repressive chromatin across the human brain. A small subset overlapping Activity-by-Contact-defined enhancers was linked to candidate immune-related genes, including MHC class II loci. By contrast, low SNP-explained VMRs were more gene-proximal and enriched for active regulatory elements. Metadata-associated VMRs showed region-, exposure-, and donor-group-dependent enrichment across SNP-explained classes, including substance use and sociodemographic variables. Together, these findings show that the most genetically anchored component of the human brain methylome is concentrated in repressive, repeat-rich chromatin compartments involved in heterochromatin maintenance and repeat silencing, distinct from the gene-proximal, exposure-associated variation less explained by nearby SNPs. By resolving this architecture in an underrepresented population, this work clarifies how inherited variation structures the brain methylome and, given the established role of these compartments in neuronal aging, informs the interpretation of epigenomic mechanisms relevant to neuropsychiatric and neurodegenerative diseases.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bennett, A., Johnson, E. K., Terry, N. N., Hemphill, J., Benjamin, K. J. M.. 2026-06-09. Local SNP-explained methylation variation reveals genetically anchored and exposure-associated methylation architecture in the human brain. https://doi.org/10.64898/2026.06.05.730443

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗